Polymorphisms associated with ion-channel disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20030162192A1
SERIAL NO

10224683

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods and materials to identify genetic abnormalities that predispose an individual to ion-channel diseases. The invention provides four polymorphic sites in the KCNQ1 gene that cause reduced conductance of the associated potassium ion channel current and a variant form of the KCNE1 gene which causes decreased conductance though the channel. The variant form of KCNE1 also acts synergistically with variants of KCNQ1 to cause further decreased conductance than either variant alone. The invention further provides polymorphisms in ion channel genes showing a higher frequency in populations afflicted with ion channel diseases or within control groups. The detection of these polymorphic sites that produce the potassium ion channel protein variants in either heterozygous or homozygous form in a subject indicates that the subject has, or is susceptible to, ion channel diseases such as congenital or acquired cardiac arrhythmia, LQT syndrome, SIDS, epilepsy, or hearing loss.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENAISSANCE PHARMACEUTICALS INC5 SCIENCE PARK NEW HAVEN CT 06511

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Curran, Mark Edward Newark, CA 7 4
Guida, Marco San Diego, CA 11 57
Rienhoff, Hugh Y JR San Carlos, CA 6 234
Sotos, John G Palo Alto, CA 17 458

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation